期刊文献+

维生素D受体基因多态性与散发性特发性甲状旁腺功能减退症的相关性 被引量:4

The relationship between gene polymorphism of vitamin D receptor and sporadic idiopathic hypoparathyroidism
下载PDF
导出
摘要 目的探讨维生素D受体(VDR)基因3′端BsmⅠ、ApaⅠ和TaqⅠ多态性与散发性特发性甲状旁腺功能减退症(SIH)的相关性,评价其与SIH患者生化指标及病情严重程度的关系。方法应用聚合酶链反应—限制性内切酶片段长度多态性分析(PCR-RFLP)确定106例SIH患者VDR基因型,测定血Ca、P、AKP、PTH水平,24 h尿Ca、P排量;记录患者智力减退、记忆力下降、癫痫发作、白内障和颅内钙化情况。结果VDR基因3′端多态性位点各等位基因频率如下:b 0.943,B 0.057,a 0.712,A 0.288,t 0.041,T 0.958,不同基因型患者生化指标和临床表现差异均无统计学意义(P>0.05)。结论VDR基因3′端多态性与SIH生化指标及病情严重程度无相关性。 Objective To investigate the relationship between polymorphisms of vitamin D receptor (VDR) gene 3'end (Bsm 1, Apa I and Taq I) and sporadic idiopathic hypoparathyroidism (SIH), and evaluate the relevance between VDR and severity of SIH. Methods To define the genotypes of 106 patients by polymerase chain reactionrestriction fragment length polymorphism (PCR-RFLP). Genome DNA was extracted by QIAGEN DNA extraction kit from peripheral white blood cell. Vitamin D receptor genotypes were determined by polymerase chain reaction-restriction fragment length polymorphism. Serum calcium, phosphorus, AKP, PTH and urinary. Ca, P levels were meas- ured. The clinical symptoms included intelligence withdraw, memory decline, episode of epilepsy, cataract and calcification of cerebral were recorded. Results In our study, the frequencies of the genotypes of vitamin D receptor gene 3'end polymorphism were as follows: b 0. 943, B 0. 057, a 0. 712, A 0. 288, t 0.041, T 0. 958. No differences of serum Ca, P, AKP, PTH and urinary Ca and clinical manifestations were found between different genotypes of patients ( P 〉 0.05 ). Condusion There was no significant relativity between polymorphisms of VDR gene 3'end and the severity of SIH.
出处 《疑难病杂志》 CAS 2010年第4期264-266,共3页 Chinese Journal of Difficult and Complicated Cases
关键词 维生素D受体 基因多态性 甲状旁腺功能减退症 特发性 散发性 Vitamin D receptor Gene polymorphism Hypoparathyroidism,sporadic,idiopathic
  • 相关文献

参考文献12

  • 1刘秋华,黄新,张鉴文.小儿非典型特发性甲状旁腺功能减退症误诊为脑瘫7例[J].疑难病杂志,2008,7(2):121-121. 被引量:4
  • 2Morrison NA,Qi JC,Tokita A,et al.Prediction of bone density from vitamin D receptor alleles[J].Nature,1994,367(6460):284-287.
  • 3Jones G,Strugnell SA,DeLuca HF.Current understanding of the molecular actions of vitamin D[J].Physiol Rev,1998,78(4):1193-1231.
  • 4Tomar N,Bora H,Singh R,et al.Presence and significance of a R110W mutation in the DNA-binding domain of GCM2 gene in patients with isolated hypoparathyroidism and their family members[J].Eur J Endocrinol,2010,162(2):407-421.
  • 5Goswami R,Brown EM,Kochupillai N,et al.Prevalence of calcium sensing receptor autoantibodies in patients with sporadic idiopathic hypoparathyroidism[J].Eur J Endocrinol,2004,150(1):9-18.
  • 6Sarin R,Tomar N,Ray D,et al.Absence of pathogenic calcium sensing receptor mutations in sporadic idiopathic hypoparathyroidism[J].Clin Endocrinol (Oxf),2006,65(3):359-363.
  • 7Goswami R,Mohapatra T,Gupta N,et al.Parathyroid hormone gene polymorphism and sporadic idiopathic hypoparathyroidism[J].J Clin Endocrinol Metab,2004,89(10):4840-4845.
  • 8Carling T,Kindmark A,Hellman P,et al.Vitamin D receptor alleles ba,and T:risk factors for sporadic primary hyperparathyroidism (HPT) but not HPT of uremia or MEN 1[J].Biochem Biophys Res Commun,1997,231(2):329-332.
  • 9Tagliabue J,Farina M,Imbasciati E,et al.Bsm I polymorphism of the vitamin D receptor gene in hyperparathyroid or hypoparathyroid dialysis patients[J].Am J Clin Pathol,1999,112(3):366-370.
  • 10Fernández E,Fibla J,Betriu A,et al.Association between vitamin D receptor gene polymorphism and relative hypoparathyroidism in patients with chronic renal failure[J].J Am Soc Nephrol,1997,8(10):1546-1552.

二级参考文献3

共引文献31

同被引文献28

  • 1Holick MF. Vitamin D deficiency [ J]. N Engl J Med, 2007, 357: 266 - 281.
  • 2Burgaz A, Byberg L, Rautiainen S, et al. Confirmed hypertension and plasma 25 (OH) D concentrations amongst elderly men [ J]. J Intern Med, 2011, 269 (2): 211-218.
  • 3Zhao G, Ford ES, Li C, et al. Independent associations of serum con- centrations of 25- hydroxyvitamin D [J]. J Hypertens, 2010, 28 (9): 1821 -1828.
  • 4Zittermann A, Vitamin D in preventive medieine: are we ignoring the evidence [ J ]. British Journal of Nutrition, 2003, 89 : 552 - 572.
  • 5Vaidya A, Pojoga L, Underwood PC, et al. The association of plasma resistin with dietary sodium manipulation, the renin - angiotensin - aldo- sterone system, and 25 - hydroxyvitamin D3 in human hypertension [J]. Clin Endoerinol, 2011, 74 (3): 294-299.
  • 6Li YC, Juan K, Wei M, et al. 1, 25 - d hydroxy vitam in D3 is a negative endocrine regulalor of the renin - angiotensin in system [ J ]. J Clin Invest, 2002, 110 (2): 229-238.
  • 7Lorraine A, Fitzpatrick, John P. Parathyroid hormone and the cardio- vascular system [ J ]. Current Osteoporosis Reports, 2008, 6 ( 2 ) : 77 - 83.
  • 8Majumdar V, Nagaraja D, Christopher R. Vitamin D status and meta- bolic syndrome in Asian Indians, 2011, 35 (8) : 1131 - 1134.
  • 9Vaidya A, Sun B, Forman JP, et al. The Fokl vitamin D receptor gene polymorphism is associated with plasma renin activity in Cauca- sians [J]. 2011, 74 (6): 783-790.
  • 10Pittas AG, Chung M, Trikalinos T, et al. Systematic Review: Vitamin D and cardiometabolic outcomes[J]. Ann Intern Med, 2010, 152(5): 307-314.

引证文献4

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部